SEC Form 4 · accession 0001156375-17-000054
CME GROUP INC. · CME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Kometer
Officer — Sr MD Chief InformationOfficer
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156375
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock Class A | Jun 9, 2017 | M | 4,125 | $110.54 | A | 54,820 | D | |
| Common Stock Class AF1 | Jun 9, 2017 | S | 4,125 | $122.4438 | D | 50,695 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $110.54 | Jun 9, 2017 | M | 4,125 | D | Jun 15, 2012 | Jun 15, 2017 | Common Stock Class A | 4,125 | 0 | D |
Explanation of responses
- F1On June 9, 2017, Mr. Kometer sold an aggregate of 4,125 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were $122.25 to $122.59. The Company maintains a record of the transactions and copies will be provided upon request.
- F2As of 6/15/2012, this option vested with respect to 100% of the granted number of shares covered by the option.